JP2013535210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535210A5 JP2013535210A5 JP2013522292A JP2013522292A JP2013535210A5 JP 2013535210 A5 JP2013535210 A5 JP 2013535210A5 JP 2013522292 A JP2013522292 A JP 2013522292A JP 2013522292 A JP2013522292 A JP 2013522292A JP 2013535210 A5 JP2013535210 A5 JP 2013535210A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- dna
- primer
- sequence
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1013153.0A GB201013153D0 (en) | 2010-08-04 | 2010-08-04 | Primer for production of closed linear DNA |
| GB1013153.0 | 2010-08-04 | ||
| PCT/GB2011/001175 WO2012017210A1 (en) | 2010-08-04 | 2011-08-04 | Production of closed linear dna using a palindromic sequence |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016202277A Division JP6689726B2 (ja) | 2010-08-04 | 2016-10-14 | パリンドローム配列を用いた閉鎖型直鎖状ｄｎａの生成 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535210A JP2013535210A (ja) | 2013-09-12 |
| JP2013535210A5 true JP2013535210A5 (enExample) | 2014-09-18 |
Family
ID=42931209
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013522292A Pending JP2013535210A (ja) | 2010-08-04 | 2011-08-04 | パリンドローム配列を用いた閉鎖型直鎖状ｄｎａの生成 |
| JP2016202277A Active JP6689726B2 (ja) | 2010-08-04 | 2016-10-14 | パリンドローム配列を用いた閉鎖型直鎖状ｄｎａの生成 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016202277A Active JP6689726B2 (ja) | 2010-08-04 | 2016-10-14 | パリンドローム配列を用いた閉鎖型直鎖状ｄｎａの生成 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9499847B2 (enExample) |
| EP (1) | EP2601312B1 (enExample) |
| JP (2) | JP2013535210A (enExample) |
| CN (1) | CN103080337B (enExample) |
| GB (1) | GB201013153D0 (enExample) |
| WO (1) | WO2012017210A1 (enExample) |
Families Citing this family (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0901593D0 (en) * | 2009-01-30 | 2009-03-11 | Touchlight Genetics Ltd | Production of closed linear DNA |
| EP2692870A1 (en) * | 2012-08-03 | 2014-02-05 | Alacris Theranostics GmbH | Method for nucleic acid amplification |
| AU2014233145A1 (en) | 2013-03-15 | 2015-09-17 | Theranos Ip Company, Llc | Nucleic acid amplification |
| JP2016521120A (ja) | 2013-03-15 | 2016-07-21 | セラノス， インコーポレイテッド | 核酸増幅 |
| US10450595B2 (en) | 2013-03-15 | 2019-10-22 | Theranos Ip Company, Llc | Nucleic acid amplification |
| US9290800B2 (en) | 2013-03-15 | 2016-03-22 | Pacific Biosciences Of California, Inc. | Targeted rolling circle amplification |
| CA2903874C (en) | 2013-03-15 | 2024-02-20 | Theranos, Inc. | Nucleic acid amplification |
| WO2015035260A1 (en) | 2013-09-06 | 2015-03-12 | Theranos, Inc. | Systems and methods for detecting infectious diseases |
| US11028388B2 (en) | 2014-03-05 | 2021-06-08 | Editas Medicine, Inc. | CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa |
| US11339437B2 (en) | 2014-03-10 | 2022-05-24 | Editas Medicine, Inc. | Compositions and methods for treating CEP290-associated disease |
| US11141493B2 (en) | 2014-03-10 | 2021-10-12 | Editas Medicine, Inc. | Compositions and methods for treating CEP290-associated disease |
| CA2948728A1 (en) | 2014-03-10 | 2015-09-17 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10) |
| WO2015148863A2 (en) | 2014-03-26 | 2015-10-01 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating sickle cell disease |
| EP3126495A1 (en) | 2014-04-02 | 2017-02-08 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating primary open angle glaucoma |
| GB201415789D0 (en) * | 2014-09-05 | 2014-10-22 | Touchlight Genetics Ltd | Synthesis of DNA |
| GB201502645D0 (en) | 2015-02-17 | 2015-04-01 | Touchlight Genetics Ltd | Method |
| EP3286571B1 (en) | 2015-04-24 | 2021-08-18 | Editas Medicine, Inc. | Evaluation of cas9 molecule/guide rna molecule complexes |
| FR3042121A1 (fr) * | 2015-10-08 | 2017-04-14 | Jean-Marc Limacher | Composition anti-tumorale |
| WO2017165862A1 (en) | 2016-03-25 | 2017-09-28 | Editas Medicine, Inc. | Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency |
| US20190309283A1 (en) * | 2016-07-19 | 2019-10-10 | Biodynamics Laboratory, Inc. | Method for preparing long-chain single-stranded dna |
| CA3032822A1 (en) | 2016-08-02 | 2018-02-08 | Editas Medicine, Inc. | Compositions and methods for treating cep290 associated disease |
| US11505821B2 (en) * | 2016-08-16 | 2022-11-22 | Touchlight IP Limited | Closed linear DNA production |
| EP3596217A1 (en) | 2017-03-14 | 2020-01-22 | Editas Medicine, Inc. | Systems and methods for the treatment of hemoglobinopathies |
| EP3622070A2 (en) | 2017-05-10 | 2020-03-18 | Editas Medicine, Inc. | Crispr/rna-guided nuclease systems and methods |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US10350307B2 (en) * | 2017-09-18 | 2019-07-16 | General Electric Company | In vivo RNA or protein expression using double-stranded concatemeric DNA including phosphorothioated nucleotides |
| ES2998052T3 (en) | 2017-10-24 | 2025-02-18 | Editas Medicine Inc | Systems and methods for treating hyper-igm syndrome |
| US20200263206A1 (en) | 2017-11-07 | 2020-08-20 | Editas Medicine, Inc. | Targeted integration systems and methods for the treatment of hemoglobinopathies |
| CA3085338A1 (en) | 2017-12-11 | 2019-06-20 | Editas Medicine, Inc. | Cpf1-related methods and compositions for gene editing |
| WO2019118806A1 (en) * | 2017-12-14 | 2019-06-20 | Solid Biosciences Inc. | Non-viral production and delivery of genes |
| KR102907245B1 (ko) | 2018-03-14 | 2026-01-05 | 에디타스 메디신, 인코포레이티드 | 혈색소병증 치료를 위한 시스템 및 방법 |
| CN108531496B (zh) * | 2018-04-04 | 2020-11-06 | 江南大学 | 一种提高外源基因mRNA数量的DNA及其应用 |
| GB201805683D0 (en) | 2018-04-05 | 2018-05-23 | Touchlight Ip Ltd | Reprogramming vectors |
| CA3104113A1 (en) | 2018-06-22 | 2019-12-26 | Asklepios Biopharmaceutical, Inc. | Vectors for gene delivery that persist within cells |
| WO2020255010A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines |
| US20220305117A1 (en) | 2019-06-18 | 2022-09-29 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai |
| MA56520A (fr) | 2019-06-18 | 2022-04-27 | Janssen Sciences Ireland Unlimited Co | Construction de l'interleukine 12 recombinante et ses utilisations |
| WO2020254876A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Virus-like particle delivery of hepatitis b virus (hbv) vaccines |
| WO2020255008A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi |
| KR20220041080A (ko) | 2019-06-18 | 2022-03-31 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | B형 간염 바이러스(hbv) 백신 및 항-pd-1 또는 항-pc-l1 항체의 조합 |
| AU2020296372A1 (en) | 2019-06-18 | 2022-02-17 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis B virus (HBV) vaccines and anti-PD-1 antibody |
| MA56534A (fr) | 2019-06-20 | 2022-04-27 | Janssen Sciences Ireland Unlimited Co | Administration par nanoporteurs glucidiques, de vaccins contre le virus de l'hépatite b (vhb) |
| AU2020295807A1 (en) | 2019-06-20 | 2022-02-17 | Janssen Sciences Ireland Unlimited Company | Lipid nanoparticle or liposome delivery of hepatitis B virus (HBV) vaccines |
| EP3792367A1 (en) | 2019-09-11 | 2021-03-17 | Universität Bielefeld | Method for the production of raav and method for the in vitro generation of genetically engineered, linear, single-stranded nucleic acid fragments containing itr sequences flanking a gene of interest |
| GB2606844B (en) | 2019-09-18 | 2025-08-06 | Aldevron Llc | Synthetic DNA vectors and methods of use |
| GB201915163D0 (en) | 2019-10-18 | 2019-12-04 | Univ Southampton | Cancer vaccine |
| CN115023503A (zh) * | 2020-01-31 | 2022-09-06 | 泰瑞斯疗法公司 | 生产闭合线性dna的方法 |
| GB202007428D0 (en) | 2020-05-19 | 2020-07-01 | Fabricnano Ltd | Polynucleotide synthesis |
| CA3181680A1 (en) * | 2020-06-12 | 2021-12-16 | University Of Rochester | Encoding and expression of ace-trnas |
| CN112111544B (zh) * | 2020-09-23 | 2022-04-01 | 复旦大学附属肿瘤医院 | 提高单链dna连接效率的方法 |
| CN116848253A (zh) * | 2021-01-22 | 2023-10-03 | 南京金斯瑞生物科技有限公司 | 用于生产目的dna序列的方法和克隆载体 |
| EP4060049B1 (en) * | 2021-03-18 | 2023-08-23 | Genomill Health Oy | Methods for accurate parallel quantification of nucleic acids in dilute or non-purified samples |
| GB202108176D0 (en) | 2021-06-08 | 2021-07-21 | Touchlight Ip Ltd | Vector |
| CA3222751A1 (en) | 2021-06-08 | 2022-12-15 | Touchlight IP Limited | Lentiviral vector |
| WO2022272297A1 (en) | 2021-06-25 | 2022-12-29 | Oxford Biomedica Solutions Llc | Adeno-associated virus packaging systems |
| WO2023285976A1 (en) | 2021-07-13 | 2023-01-19 | Stonehaven Incubate AG | Composition and uses thereof |
| GB202114105D0 (en) | 2021-10-01 | 2021-11-17 | Fabricnano Ltd | Nucleotide synthesis |
| EP4419677A4 (en) | 2021-10-18 | 2025-09-24 | Flagship Pioneering Innovations Vii Llc | DNA COMPOSITIONS AND RELATED METHODS |
| US20230323395A1 (en) | 2021-12-15 | 2023-10-12 | Homology Medicines, Inc. | Methods and compositions for the production of adeno-associated virus |
| CA3243028A1 (en) | 2021-12-20 | 2025-04-07 | Zoetis Services Llc | USE OF INTERFERON AS AN ADJUVANT IN VACCINES |
| CN118414349A (zh) | 2021-12-20 | 2024-07-30 | 硕腾服务有限责任公司 | 用于在细胞膜上表达抗原的组合物和方法 |
| EP4453008A1 (en) | 2021-12-20 | 2024-10-30 | Zoetis Services LLC | Compositions and methods for prevention of piscine myocarditis |
| CN114561372B (zh) * | 2022-04-27 | 2022-07-26 | 南京巨匠生物科技有限公司 | Bst DNA聚合酶突变体及其应用和产品、基因、重组质粒和基因工程菌 |
| EP4293101A1 (en) | 2022-06-14 | 2023-12-20 | Asklepios Biopharmaceutical, Inc. | Reactor with temperature control and method of using the same |
| CN119698477A (zh) * | 2022-08-10 | 2025-03-25 | 镇江蓬勃生物科技有限公司 | 线性闭合dna的制备方法及该方法所用质粒 |
| WO2024039652A1 (en) | 2022-08-16 | 2024-02-22 | Aldevron, L.L.C. | Cell-free method of producing synthetic circular nucleic acid |
| WO2024058155A1 (ja) * | 2022-09-12 | 2024-03-21 | 株式会社カネカ | 二本鎖環状ｄｎａベクター、直鎖状共有結合閉鎖ｄｎａの作製方法、並びにプロテロメラーゼ及びエンドヌクレアーゼを含む融合ポリペプチド |
| AU2023342975A1 (en) | 2022-09-12 | 2025-03-20 | Zoetis Services Llc | Method of administration of aquaculture vaccines |
| CN117778498A (zh) * | 2022-09-26 | 2024-03-29 | 深圳瑞吉生物科技有限公司 | 一种无细胞制备mRNA转录模板的方法 |
| AU2023352042A1 (en) | 2022-09-29 | 2025-04-10 | Ceva Hampton Limited | Vaccine construct and uses thereof |
| WO2024121354A1 (en) * | 2022-12-08 | 2024-06-13 | Keygene N.V. | Duplex sequencing with covalently closed dna ends |
| DK202370610A1 (en) | 2022-12-13 | 2024-07-12 | Zoetis Services Llc | Methods of vaccine administration to salmonids |
| WO2024197081A1 (en) | 2023-03-20 | 2024-09-26 | Hc Bioscience, Inc. | Minimally-sized dna threads for trna therapy |
| CN116606834A (zh) * | 2023-04-10 | 2023-08-18 | 天津中合基因科技有限公司 | 多种具有切割连接活性的原端酶及其应用 |
| WO2024256842A1 (en) | 2023-06-16 | 2024-12-19 | Touchlight IP Limited | Therapeutic transfection |
| CN121816413A (zh) | 2023-08-18 | 2026-04-07 | 镇江蓬勃生物科技有限公司 | 纯化核酸分子的方法 |
| US11981936B1 (en) | 2023-09-29 | 2024-05-14 | New England Biolabs, Inc. | TelA variants, compositions, and methods |
| GB202319998D0 (en) | 2023-12-22 | 2024-02-07 | Touchlight Ip Ltd | duplexing method |
| FR3160186A1 (fr) | 2024-03-13 | 2025-09-19 | Odimma Therapeutics | Vecteur non-viral pour transcription augmentee |
| WO2025202929A1 (en) * | 2024-03-29 | 2025-10-02 | Pfizer Inc. | Methods for producing nucleic acids |
| WO2025250742A1 (en) * | 2024-05-30 | 2025-12-04 | Aclarity Genomics, Inc. | Amplification of macromolecules |
| WO2025264964A1 (en) | 2024-06-20 | 2025-12-26 | Zoetis Services Llc | Vaccines against tenacibaculum finnmarkense |
| EP4729632A1 (en) | 2024-10-18 | 2026-04-22 | AskBio Inc. | Method of synthesizing dna |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| JPH03236781A (ja) * | 1990-02-13 | 1991-10-22 | Takara Shuzo Co Ltd | ランダムプライマーキット及びその使用方法 |
| JPH06500014A (ja) | 1990-07-25 | 1994-01-06 | シンジーン，インコーポレイテッド | 多数の核酸相補体を生成させる環状伸長法 |
| FR2675803B1 (fr) | 1991-04-25 | 1996-09-06 | Genset Sa | Oligonucleotides fermes, antisens et sens et leurs applications. |
| US6953676B1 (en) | 1992-05-01 | 2005-10-11 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
| WO1994003624A1 (en) * | 1992-08-04 | 1994-02-17 | Auerbach Jeffrey I | Methods for the isothermal amplification of nucleic acid molecules |
| US5714320A (en) | 1993-04-15 | 1998-02-03 | University Of Rochester | Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides |
| DE69429038T2 (de) | 1993-07-28 | 2002-03-21 | Pe Corporation (Ny), Norwalk | Vorrichtung und Verfahren zur Nukleinsäurevervielfältigung |
| WO1995011923A1 (en) * | 1993-10-29 | 1995-05-04 | Dana-Farber Cancer Institute, Inc. | A novel tumor marker and novel method of isolating same |
| FR2732971B1 (fr) | 1995-04-13 | 1997-07-04 | Genset Sa | Oligonucleotide sens inhibiteur de virus herpes simplex (hsv) a structure en haltere |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| US6143495A (en) | 1995-11-21 | 2000-11-07 | Yale University | Unimolecular segment amplification and sequencing |
| DE19648625A1 (de) | 1996-11-13 | 1998-05-14 | Soft Gene Gmbh | Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer |
| JPH10234399A (ja) | 1997-02-28 | 1998-09-08 | Shinkinrui Kinou Kaihatsu Kenkyusho:Kk | ピシウム属菌検出用の核酸配列 |
| US6054274A (en) | 1997-11-12 | 2000-04-25 | Hewlett-Packard Company | Method of amplifying the signal of target nucleic acid sequence analyte |
| ATE400358T1 (de) | 1997-12-24 | 2008-07-15 | Cepheid | Vorrichtung und verfahren zur lyse |
| CA2317896C (en) | 1998-01-09 | 2004-08-10 | University Of Utah Research Foundation | Method for in vitro amplification of circular dna |
| DE19826758C1 (de) | 1998-06-15 | 1999-10-21 | Soft Gene Gmbh | Darstellung von linearen kovalent geschlossenen DNA-Molekülen als Expressionskonstrukte |
| CA2342838A1 (en) | 1998-09-15 | 2000-03-23 | Yale University | Molecular cloning using rolling circle amplification |
| EP1203078B1 (de) | 1999-07-08 | 2005-05-04 | Mologen Forschungs-, Entwicklungs- und Vertriebs GmbH | Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze |
| AU2001250572A1 (en) * | 2000-04-07 | 2001-10-23 | Epigenomics Ag | Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations |
| GB0018120D0 (en) | 2000-07-24 | 2000-09-13 | Fermentas Ab | Nuclease |
| JP2002051784A (ja) * | 2000-08-09 | 2002-02-19 | Toyobo Co Ltd | 核酸の増幅方法及び標識核酸の調製方法 |
| US6977148B2 (en) | 2001-10-15 | 2005-12-20 | Qiagen Gmbh | Multiple displacement amplification |
| US20030077611A1 (en) | 2001-10-24 | 2003-04-24 | Sention | Methods and systems for dynamic gene expression profiling |
| US20030170693A1 (en) * | 2001-12-21 | 2003-09-11 | George Chaconas | Assay for identifying modulators of Borrelia telomere resolvase |
| US7081339B2 (en) | 2002-04-12 | 2006-07-25 | Primera Biosystems, Inc. | Methods for variation detection |
| CA2492203A1 (en) | 2002-07-12 | 2004-01-22 | Affymetrix, Inc. | Synthetic tag genes |
| ES2270120T3 (es) | 2002-09-23 | 2007-04-01 | Mologen Ag | Vacuna contra infecciones causadas por oncovirus tales como el virus de la leucemia felina. |
| US7955795B2 (en) | 2003-06-06 | 2011-06-07 | Qiagen Gmbh | Method of whole genome amplification with reduced artifact production |
| WO2004065582A2 (en) | 2003-01-15 | 2004-08-05 | Dana-Farber Cancer Institute, Inc. | Amplification of dna in a hairpin structure, and applications |
| EP1594987B1 (en) | 2003-02-21 | 2009-05-27 | GeneForm Technologies Limited | Nucleic acid sequencing methods, kits and reagents |
| EP1706502A4 (en) | 2003-11-26 | 2007-05-23 | Eppendorf Ag | METHODS AND COMPOSITIONS FOR IN VITRO AMPLIFICATION OF EXTRACHROMOSOMIC NUCLEIC ACID |
| JP3972106B2 (ja) * | 2004-03-03 | 2007-09-05 | 大学共同利用機関法人情報・システム研究機構 | ゲノムライブラリー作製方法、および同方法により作製されたゲノムライブラリー |
| CN101103122A (zh) * | 2004-12-11 | 2008-01-09 | 西托吉尼克斯公司 | 高质量核酸的无细胞生物合成及其用途 |
| WO2006063355A2 (en) | 2004-12-11 | 2006-06-15 | Cytogenix , Inc. | Cell free biosynthesis of high-quality nucleic acid and uses thereof |
| WO2006108423A2 (en) | 2005-04-12 | 2006-10-19 | In Situ Rcp A/S Under Founding | Methods for production of oligonucleotides |
| ATE474937T1 (de) | 2005-04-29 | 2010-08-15 | Synthetic Genomics Inc | Amplifikation und klonierung einzelner dna- moleküle mittels rolling-circle-amplifikation |
| EP1974037B1 (en) | 2006-01-12 | 2012-03-14 | Lucigen Corporation | Linear vectors, host cells and cloning methods |
| EP3527671A1 (en) | 2006-10-06 | 2019-08-21 | Applied DNA Sciences Inc. | System for a continuous rapid thermal cycle system |
| US20080118917A1 (en) * | 2006-11-21 | 2008-05-22 | Applera Corporation | Isothermal SNP Detection Method |
| US8921072B2 (en) * | 2008-09-02 | 2014-12-30 | General Electric Compnay | Methods to generate DNA mini-circles |
| GB0901593D0 (en) | 2009-01-30 | 2009-03-11 | Touchlight Genetics Ltd | Production of closed linear DNA |
| JP5182949B2 (ja) * | 2009-03-31 | 2013-04-17 | 浜名部品工業株式会社 | ヨークの製造方法及び製造装置 |
| US9114399B2 (en) | 2010-08-31 | 2015-08-25 | Canon U.S. Life Sciences, Inc. | System and method for serial processing of multiple nucleic acid assays |
| EP2692870A1 (en) | 2012-08-03 | 2014-02-05 | Alacris Theranostics GmbH | Method for nucleic acid amplification |
| KR102014989B1 (ko) | 2013-04-15 | 2019-08-27 | 삼성전자주식회사 | 폴리뉴클레오티드 및 그의 용도 |
-
2010
- 2010-08-04 GB GBGB1013153.0A patent/GB201013153D0/en not_active Ceased
-
2011
- 2011-08-04 WO PCT/GB2011/001175 patent/WO2012017210A1/en not_active Ceased
- 2011-08-04 US US13/814,106 patent/US9499847B2/en active Active
- 2011-08-04 JP JP2013522292A patent/JP2013535210A/ja active Pending
- 2011-08-04 EP EP11746284.6A patent/EP2601312B1/en active Active
- 2011-08-04 CN CN201180038378.5A patent/CN103080337B/zh active Active
-
2016
- 2016-10-14 JP JP2016202277A patent/JP6689726B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Martínez-Jiménez et al. | Alternative solutions and new scenarios for translesion DNA synthesis by human PrimPol | |
| KR102369533B1 (ko) | 뉴클레아제 프로파일링 시스템 | |
| AU2024278094A1 (en) | Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA) | |
| EP3470529B1 (en) | Nucleic acid isothermal self-amplification method | |
| JP4448619B2 (ja) | 組換えポリヌクレオチド配列をＩｎｖｉｔｒｏで得る方法、配列バンク及びかくして得られた配列 | |
| EP3559269B1 (en) | Single stranded circular dna libraries for circular consensus sequencing | |
| JP2018537955A5 (enExample) | ||
| KR20220034253A (ko) | 스위칭가능한 ｃａｓ９ 뉴클레아제 및 그의 용도 | |
| JP2024518546A (ja) | 修飾されたｍＲＮＡ、修飾された非コードＲＮＡ、およびその使用 | |
| JP2020512845A5 (enExample) | ||
| JP2017093448A5 (enExample) | ||
| JP2017504360A5 (enExample) | ||
| KR101984700B1 (ko) | 폴리뉴클레오티드 및 그의 용도 | |
| CN104114702A (zh) | 模板转换用于dna合成的用途 | |
| JP2014527401A5 (enExample) | ||
| JP2009530257A5 (enExample) | ||
| US20230357790A1 (en) | Self-targeting expression vector | |
| CN103080337A (zh) | 利用回文序列生产闭合线性dna | |
| US12157911B2 (en) | Method for generating single-stranded circular DNA libraries for single molecule sequencing | |
| CA2896537C (en) | Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response | |
| JP2015532097A5 (enExample) | ||
| JP2018533956A5 (enExample) | ||
| JP2024538168A5 (enExample) | ||
| JP2021526798A5 (enExample) | ||
| WO2011142798A3 (en) | Methods of preparing targeted aptamer prodrugs |